StockData
Apnimed, Inc. logo

Apnimed, Inc. (APMD) stock

APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$17.80+1.52 (+9.34%)

Close on Nov 17, 2026Market cap $85.47MP/E –Yield –

Apnimed enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Apnimed's enterprise value was -$51.96M on Nov 11, 2026.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$51.96M–

More Apnimed figures

See a number that looks wrong?